Work

Abstract CT131: Entrectinib in NTRK-fusion positive (NTRK-FP) non-small cell lung cancer (NSCLC): Integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1 and ALKA-372-001)

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2019-ct131

Authors: Robert Doebele, Luis Paz-Ares, Anna F. Farago, Stephen V. Liu, Sant P. Chawla, Diego Tosi, Collin M. Blakely, John C. Krauss, Darren Sigal, Lyudmila Bazhenova, Tom John, Benjamin Besse, Jürgen Wolf, Takashi Seto, Edna Chow-Maneval, Chenglin Ye, Brian Simmons, George D. Demetri

Institutions: Hospital Universitario 12 De Octubre, Massachusetts General Hospital, Georgetown University, Sarcoma Oncology Center, Université de Montpellier, University of California, San Francisco, University of Michigan, Scripps Clinic, University of California San Diego, Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Institut Gustave Roussy, University Hospital Cologne, National Hospital Organization Kyushu Cancer Center, Ignyta (United States), Genentech, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2953456310

Cites:

Cited by: 15

Related to: 10